Related Experiment Video
Updated: Aug 6, 2026
10:17
An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
Published on: April 26, 2019
Glycosylation modification: a trigger for obesity and its complications?
Changzan Wang1, Wenying Yi1, Xianghui Li1
1First Clinical Medical College of Xinjiang Medical University, Urumqi, 830011, China.
Molecular Medicine (Cambridge, Mass.)
|July 17, 2026
Summary
Glycosylation modifications are crucial in obesity and metabolic diseases. Understanding these changes and their interaction with other protein modifications offers new therapeutic targets for obesity treatment.
Area of Science:
- Biochemistry
- Metabolic Diseases
- Molecular Biology
Background:
- Obesity and related metabolic diseases pose a global health challenge.
- Pathophysiological mechanisms of obesity are complex, requiring novel interventions.
- Glycosylation modifications are increasingly recognized for their role in obesity.
Purpose of the Study:
- To review the role of glycosylation in obesity and its complications.
- To identify specific glycosylation sites involved in obesity.
- To explore interactions between glycosylation and other post-translational modifications (PTMs).
Main Methods:
- Literature review of recent research on glycosylation and obesity.
- Analysis of studies investigating glycosylation sites and PTM interactions.
- Discussion of O-linked β-N-acetylglucosamine (O-GlcNAc) signaling pathways.
Main Results:
- Glycosylation plays a significant role in the onset and progression of obesity.
- Specific glycosylation sites are implicated in regulating obesity.
- Interactions between glycosylation and other PTMs influence obesity mechanisms.
Conclusions:
- Glycosylation is a key regulator in obesity and metabolic diseases.
- Further research into glycosylation sites and PTM crosstalk can yield novel therapeutic strategies.
- Understanding O-GlcNAc signaling offers new perspectives for clinical interventions.
Related Concept Videos
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:25Protein Glycosylation
Glycosylation, the most common post-translational modification for proteins, serves diverse functions. Adding sugars to proteins makes the proteins more resistant to proteolytic digestion. Glycosylated proteins can act as markers and receptors to promote cell-cell adhesion. Additionally, they have many essential quality control functions in the cell, such as correct protein folding and facilitating transport of misfolded proteins to the cytosol, which can be degraded.
Glycosylation occurs in...
Glycosylation occurs in...
01:05Proteoglycans
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:24Oligosaccharide Assembly
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Multiple sugar molecules that may or may...